vimarsana.com

Latest Breaking News On - Disease biomarkers marketis - Page 1 : vimarsana.com

Anti-radiation Drugs Market to Reach US$ 9 6 Bn by 2031, TMR Study

/PRNewswire/ The global anti-radiation drugs market was valued at US$ 3.4 Bn in 2021 and is anticipated to grow at a CAGR of 9.9% from 2022 to 2031..

United statesDiethylenetriamine pentaacetateAsia pacificNikhil sawlaniPremium researchChrysalis biotherapeutics incHealthcare research reportsby transparency marketPluri incMore research insights on leading industriesCellphire incMission pharmacal companyHumanetics corporationVarco pharmaceuticalsAnbex incTransparency market researchEnzychem lifesciences corporation

Transparency Market Research: Anti-radiation Drugs Market to Reach US$ 9 6 Bn by 2031, TMR Study

Rise in investment in R&D by pharma and biotech companies for the development of effective drugs for acute radiation syndrome or ARS propels market growthIncrease in efforts by pharmaceutical

United statesKostenloser wertpapierhandelDiethylenetriamine pentaacetateAsia pacificNikhil sawlaniPremium researchChrysalis biotherapeutics incPluri incMore research insights on leading industriesCellphire incMission pharmacal companyHumanetics corporationVarco pharmaceuticalsAnbex incHealthcare researchTransparency market research

vimarsana © 2020. All Rights Reserved.